1-METHYLHYDANTOIN
|
甲酰乙內(nèi)脲
|
616-04-6
|
oxiracetam impurity III
|
奧拉西坦雜質(zhì)III
|
62833-66-3
|
(R)-4-Hydroxy-2-pyrrolidone
|
奧拉西坦雜質(zhì)A
|
25747-41-5
|
(R)-4-Hydroxy-2-pyrrolidone
|
奧拉西坦雜質(zhì)A
|
62624-29-7
|
GLYCINE ANHYDRIDE
|
甘氨酸酐(奧拉西坦相關(guān))
|
106-57-0
|
oxiracetaM related substance ISF3886
|
奧拉西坦進(jìn)口標(biāo)準(zhǔn)雜質(zhì)ISF3886
|
120428-80-0
|
oxiracetam impurity VII
|
奧拉西坦雜質(zhì)VII
|
62613-81-4
|
Dabigatran Etexilate Impurity 64
|
達(dá)比加群酯雜質(zhì)64
|
355809-32-4
|
Dabigatran Etexilate Impurity 67
|
達(dá)比加群酯雜質(zhì)67
|
1848337-06-3
|
Dabigatran etexilate Impurity R
|
達(dá)比加群乙二酸雜質(zhì)R(達(dá)比加群酯雜質(zhì))
|
1610758-20-7
|
Desethyl Dabigatran Etexilate
|
去乙基達(dá)比加群酯(達(dá)比加群酯雜質(zhì))
|
212321-78-3
|
Dabigatran iMpurity F
|
達(dá)比加群雜質(zhì)F
|
1642853-67-5
|
INDEX NAME NOT YET ASSIGNED
|
達(dá)比加群酯雜質(zhì)
|
2518152-88-8
|
Dabigatran Impurity 18
|
達(dá)比加群雜質(zhì) 18
|
1422435-35-5
|
Dabigatran Impurity 9
|
達(dá)比加群酯雜質(zhì)9
|
1408238-41-4
|
Dabigatran etexilate Imp.C
|
達(dá)比加群酯雜質(zhì)C
|
1408238-40-3
|
Dabigatran Impurity 24
|
達(dá)比加群酯雜質(zhì)24(達(dá)比加群酯雜質(zhì))
|
2243727-83-3
|
Dabigatran Impurity 10 (DABRC-10)
|
達(dá)比加群雜質(zhì)10(DABRC-10)
|
1304574-20-6
|
1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester
|
達(dá)比加群酯雜質(zhì)
|
1970195-83-5
|
Dabigatran iMpurity G
|
達(dá)比加群雜質(zhì)G
|
1912458-32-2
|
1H-Benzimidazole-5-carboxylic acid, 2-[[[4-[(E)-amino[[(hexyloxy)carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-
|
達(dá)比加群酯雜質(zhì)67
|
2459303-30-9
|
Dabigatran iMpurity E
|
達(dá)比加群雜質(zhì)E
|
1456889-80-7
|
Dabigatran Etexilate Impurity H
|
達(dá)比加群酯雜質(zhì)H
|
211915-00-3
|
1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]-
|
7-(丁-2-炔-1-基)-3-甲基-8-(甲基氨基)-1-((4-甲基喹唑啉-2-基)甲基)-1H-嘌呤-2,6-(3H,7H)-二酮(利格列汀雜質(zhì))
|
2468656-63-3
|
Vardenafil Impurity 7
|
伐地那非雜質(zhì) 7
|
1009013-42-6
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-5,7-dimethyl-
|
伐地那非雜質(zhì)
|
224785-72-2
|
benzofuran-6-carboxylic acid(Lifitegrast Impurity 29)
|
苯并呋喃-6-羧酸( 立他司特雜質(zhì))
|
77095-51-3
|
Acetylvardenafil
|
乙酰伐地那非
|
1261351-28-3
|
ethyl benzofuran-6-carboxylate
|
立他司特雜質(zhì)32
|
1289646-90-7
|
Linagliptin Impurity 14
|
利格列汀雜質(zhì)14
|
2416949-69-2
|
(S)-2-(tert-butoxycarbonylamino)-3-(3-(methylsulfonyl)phenyl) propanoic acid
|
BOC-3-砜基苯丙氨酸(立他司特雜質(zhì)C-1)
|
1289646-76-9
|
4-Aminobenzamidine dihydrochloride
|
4-氨基苯甲脒二鹽酸鹽(達(dá)比加群雜質(zhì))
|
2498-50-2
|
C3-NITRO-4-METHYLAMINO-BENZOYLCHLORIDE
|
3-硝基-4-甲胺基-苯甲酰氯(達(dá)比加群雜質(zhì))
|
82357-48-0
|
Dabigatran Impurity
|
達(dá)比加群雜質(zhì)
|
2096992-14-0
|
Dabigatran iMpurity D
|
達(dá)比加群雜質(zhì)D
|
1610758-22-9
|
Dabigatran Impurity 10
|
達(dá)比加群脂雜質(zhì)10
|
1422435-37-7
|
Dabigatran Etexilate iMpurity 1
|
達(dá)比加群酯雜質(zhì)1
|
1610758-19-4
|
N,N-DIMETHYL-GUANIDINE
|
1,1-二甲基胍(磷酸肌酸鈉雜質(zhì))
|
6145-42-2
|
Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate
|
3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙酯(達(dá)比加群雜質(zhì))
|
212322-56-0
|
Cyanamide, N,N-dicyano-
|
磷酸肌酸鈉雜質(zhì)
|
97904-31-9
|
3-(pyridin-2-ylamino)propanoic acid
|
3-(2-吡啶胺)丙酸(達(dá)比加群雜質(zhì))
|
104961-64-0
|
Dabigatran Etexilate Impurity 82
|
達(dá)比加群酯雜質(zhì)82
|
1771756-20-7
|
N-[3-AMino-4-(MethylaMino)benzoyl]-N-2-pyridinyl-β-alanine Methyl Ester
|
達(dá)比加群酯雜質(zhì)
|
1369510-38-2
|
Dabigatran Etexilate iMpurity D
|
達(dá)比加群酯雜質(zhì)D
|
1422435-40-2
|
ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
|
達(dá)比加群雜質(zhì)J
|
1354727-65-3
|
Dabigatran Etexilate iMpurity C4
|
鄰丁基達(dá)比加群乙酯(達(dá)比加群雜質(zhì))
|
1416446-43-9
|
ethyl 3-(2-(chloroMethyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate
|
達(dá)比加群酯中間體3
|
1307233-94-8
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester
|
達(dá)比加群甲酯雜質(zhì)
|
771459-37-1
|
Dabigatran Etexilate iMpurity O
|
達(dá)比加群酯雜質(zhì)O
|
1349500-09-9
|
N-Desethyl-N-Methyl Vardenafil
|
N-去乙基-N-甲基伐地那非(伐地那非雜質(zhì))
|
224785-87-9
|
midazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-hydroxyphenyl)-5-methyl-7-propyl-
|
伐地那非雜質(zhì)
|
910554-78-8
|
1-Methylguanidine hydrochloride
|
1-甲基胍鹽酸鹽(磷酸肌酸鈉雜質(zhì))
|
21770-81-0
|
Dibanzyloxy phosphatecreatinine
|
二芐氧基磷酰基肌酸酐(磷酸肌酸鈉雜質(zhì))
|
19208-69-6
|
Sodium sarcosinate
|
肌氨酸鈉
|
4316-73-8
|
4-hydroxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazine-2-yl)phenylsulfonic acid
|
伐地那非雜質(zhì)
|
910554-77-7
|
Linagliptin impurity 16
|
利拉利汀雜質(zhì)16
|
1955514-80-3
|
Vardenafil Impurity 13
|
伐地那非雜質(zhì)13
|
2169247-39-4
|
2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)
|
伐地那非雜質(zhì)D
|
1255919-03-9
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-ethoxyphenyl)-5,7-dimethyl-
|
伐地那非雜質(zhì)
|
224789-20-2
|
N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide
|
伐地那非雜質(zhì)
|
1417529-59-9
|
N-Desethyl Vardenafil
|
N-去乙基伐地那非(伐地那非雜質(zhì))
|
448184-46-1
|
Hydroxyvardenafil
|
羥基伐地那非(伐地那非雜質(zhì))
|
224785-98-2
|
VARDENAFIL, DIHYDROCHLORIDE SALT
|
偽伐地那非
|
224788-34-5
|
Linagliptin Impurity H
|
利格列汀雜質(zhì)H
|
1646355-34-1
|
2-QuinazolineMethanol, 4-Methyl-
|
利拉利汀雜質(zhì)N
|
13535-91-6
|
Linagliptin Impurity 51
|
利格列汀雜質(zhì)51
|
2138392-83-1
|
Vardenafil EP Impurity B
|
伐地那非EP雜質(zhì)B
|
437717-43-6
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-
|
N-氧化伐地那非(伐地那非雜質(zhì))
|
448184-48-3
|
INDEX NAME NOT YET ASSIGNED
|
利格列汀雜質(zhì)
|
2748491-45-2
|
Linagliptin Impurity D
|
利格列汀雜質(zhì)D
|
666816-91-7
|
Linagliptin Impurity F
|
利格列汀雜質(zhì)F
|
1673546-62-7
|
Linagliptin iMpurity E
|
利拉利汀雜質(zhì)E
|
1446263-38-2
|
Linagliptin Impurity K
|
利格列汀雜質(zhì)K
|
1638744-06-5
|
Linagliptin Impurity 33
|
利格列汀雜質(zhì)33
|
2443735-53-1
|
Linagliptin N-Acetyl Impurity
|
利格列汀N-乙酰雜質(zhì)
|
1803079-49-3
|
Linagliptin Impurity 3
|
利格列汀雜質(zhì)3
|
2749409-37-6
|
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity)
|
達(dá)比加群酯雜質(zhì)G
|
1408238-36-7
|
Dabigatran iMpurity K
|
達(dá)比加群雜質(zhì)K
|
1580491-16-2
|
Dabigatran Impurity 5
|
達(dá)比加群酯雜質(zhì)5
|
2225986-95-6
|
Dabigatran Impurity 38
|
達(dá)比加群雜質(zhì)38
|
1416446-40-6
|
Dabigatran Etexilate Impurity O HCl
|
達(dá)比加群酯雜質(zhì)O鹽酸鹽
|
211914-50-0
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, labeled with tritium
|
達(dá)比加群酯雜質(zhì)B
|
1919877-45-4
|
Dabigatran Etexilate Impurity X
|
達(dá)比加群酯雜質(zhì)X
|
1643377-48-3
|
Dabigatran Etexilate Impurity B
|
達(dá)比加群酯雜質(zhì)B
|
211914-51-1
|
β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
|
達(dá)比加群雜質(zhì)20
|
1873316-88-1
|
Dabigatran Impurity 29
|
達(dá)比加群酯雜質(zhì)29
|
1610758-21-8
|
Dabigatran Impurity p
|
達(dá)比加群酯雜質(zhì)F
|
1408238-37-8
|
Dabigatran Etexilate iMpurity I
|
達(dá)比加群乙二酸雜質(zhì)I
|
255706-13-9
|
Dabigatran Impurity 19
|
達(dá)比加群雜質(zhì) 19
|
2225986-94-5
|
Dabigatran etexilate C5
|
達(dá)比加群酯雜質(zhì)C5
|
1416446-45-1
|
Dabigatran Etexilate iMpurity H
|
達(dá)比加群酯雜質(zhì)H
|
1702936-92-2
|
Dabigatran Impurity 16
|
達(dá)比加群雜質(zhì)10
|
211916-39-1
|
Dabigatran iMpurity O
|
達(dá)比加群雜質(zhì)O
|
948551-71-1
|
Dabigatran iMpurity L
|
達(dá)比加群雜質(zhì)L
|
1422435-41-3
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, hydrochloride (1:)
|
達(dá)比加群酯雜質(zhì)O鹽酸鹽
|
1187067-70-4
|
Dabigabine mesylate - intermediate 2
|
達(dá)比加群酯雜質(zhì)O鹽酸鹽
|
1223061-75-3
|
Clobetasone
|
氯倍他松
|
54063-32-0
|
9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
|
二丙酸倍他米松EP雜質(zhì)B
|
5534-13-4
|
oxiracetam impurity IV
|
奧拉西坦雜質(zhì)IV
|
77191-37-8
|
oxiracetam impurity VI
|
奧拉西坦雜質(zhì)VI
|
85614-52-4
|
(R)-4-Hydroxy-2-pyrrolidone
|
奧拉西坦雜質(zhì)A
|
22677-21-0
|